Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam flag Vietnam · Delayed Price · Currency is VND
63,400
+100 (0.16%)
At close: Feb 9, 2026

HNX:DP3 Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
438,006417,485409,731485,074381,077
Revenue Growth (YoY)
4.92%1.89%-15.53%27.29%-3.70%
Cost of Revenue
150,345141,432128,228148,536117,447
Gross Profit
287,661276,054281,503336,538263,630
Selling, General & Admin
117,174139,372144,618208,717151,491
Operating Expenses
117,174139,372144,618208,717151,491
Operating Income
170,487136,682136,885127,821112,139
Interest Expense
-694.75-161.5-1,594-6,475-449
Interest & Investment Income
22,83415,46321,66510,7327,360
Currency Exchange Gain (Loss)
-64.63-133.63-15.04--
Other Non Operating Income (Expenses)
262.86-97.5260.974,412-839.85
EBT Excluding Unusual Items
192,825151,752157,001136,490118,210
Gain (Loss) on Sale of Assets
30163.22.28--
Pretax Income
192,855151,915157,003136,490118,210
Income Tax Expense
39,29430,74331,74027,66523,905
Net Income
153,561121,172125,263108,82494,305
Net Income to Common
153,561121,172125,263108,82494,305
Net Income Growth
26.73%-3.27%15.11%15.40%-17.32%
Shares Outstanding (Basic)
2121212321
Shares Outstanding (Diluted)
2121212321
Shares Change (YoY)
---5.00%5.27%-0.00%
EPS (Basic)
7142.415635.905826.224808.404386.40
EPS (Diluted)
7142.415635.905826.224808.404386.40
EPS Growth
26.73%-3.27%21.17%9.62%-17.32%
Free Cash Flow
242,07690,452146,69984,12625,862
Free Cash Flow Per Share
11259.394207.106823.213717.111202.91
Dividend Per Share
--3000.000-2400.000
Gross Margin
65.67%66.12%68.70%69.38%69.18%
Operating Margin
38.92%32.74%33.41%26.35%29.43%
Profit Margin
35.06%29.02%30.57%22.43%24.75%
Free Cash Flow Margin
55.27%21.67%35.80%17.34%6.79%
EBITDA
182,044149,542150,864--
EBITDA Margin
41.56%35.82%36.82%--
D&A For EBITDA
11,55612,86113,980--
EBIT
170,487136,682136,885127,821112,139
EBIT Margin
38.92%32.74%33.41%26.35%29.43%
Effective Tax Rate
20.38%20.24%20.22%20.27%20.22%
Revenue as Reported
438,006417,485409,731485,074381,077
Source: S&P Global Market Intelligence. Standard template. Financial Sources.